Dexcom
As on 14 Mar, 2026 | 01:29 IST
| Open | 65.26 |
| Previous Close | 65.26 |
| Beta | -0.10 |
| High | 65.78 |
| Low | 63.82 |
| TTM EPS See historical trend | 2.09(+26.67% YoY) |
| 52 Week High | 89.88 |
| 52 Week Low | 54.13 |
| TTM PE See historical trend | 30.73(Low PE) |
| Mkt. Cap ($ Billion) | 25.09 |
| Dividend Yield | -- |
Advanced Chart
*Delayed by 20 seconds
MC Technicals
| Days | |
|---|---|
| 5 | 66.46 |
| 10 | 69.1 |
| 20 | 70.77 |
| 50 | 70.51 |
| 100 | 67.32 |
| 200 | 73.23 |
Returns
| 1 Week | -5.77% | |
| 1 Month | -8.32% | |
| 3 Months | -4.01% | |
| YTD | -3.24% | |
| 1 Year | -6.20% | |
| 3 Years | -41.96% |
Financialsin million $
Peers
| Name | Price ($) | Change% | M.Cap(Billion $) | TTM PE | TTM EPS | DY | 52 wk high/low | Technical Rating | |
|---|---|---|---|---|---|---|---|---|---|
| J&J | 241.49 | -0.23 | 582.11 | 22.37 | 10.80 | 2.50 | 251.71/143.68 | -0.67 | Very Bearish |
| Abbott | 108.03 | -0.10 | 187.37 | 20.98 | 5.15 | 1.92 | 139.02/105.28 | -4.07 | Neutral |
| Stryker | 336.77 | -0.13 | 128.16 | 24.71 | 13.63 | 0.97 | 404.81/328.33 | -7.99 | Bearish |
| Medtronic | 87.07 | -0.49 | 105.34 | 18.35 | 4.75 | 2.81 | 106.31/79.59 | -12.48 | Bullish |
| Boston Scientific | 69.17 | 0.90 | 101.84 | 22.66 | 3.05 | -- | 109.50/67.56 | -7.55 | Bearish |
Market news
- US stocks close down as oil spikes 12%, job market weakensMarch 7, 2026 9:27 AM
- Wall Street ends higher after Supreme Court rules against Trump tariffsFebruary 21, 2026 8:06 AM
- S&P 500 ends up slightly as tech dips, inflation coolsFebruary 14, 2026 9:22 AM
- Dow Jones Industrial Average breaks 50,000 level for first timeFebruary 7, 2026 9:16 AM
About the company
Dexcom, Inc. is a medical device company. The Company is primarily focused on the design, development and commercialization of continuous glucose monitoring (CGM) systems for use by people with diabetes and by healthcare providers. Its products include Dexcom G6 and Dexcom Share. The G6 is a CGM system that can be used as part of an integrated system with other compatible medical devices and electronic interfaces, which may include automated insulin dosing systems, insulin pumps, blood glucose meters or other electronic devices used for diabetes management. Its Dexcom Share remote monitoring system, offered for use with its Dexcom system, uses an app on the patient’s iPhone, iPod touch, iPad or Android mobile device to securely and wirelessly transmit glucose information to the cloud and then to apps on the mobile devices of up to five designated recipients, who can remotely monitor a patient’s glucose information and receive alert notifications.